Kate Mahon

1.9k total citations
55 papers, 1.2k citations indexed

About

Kate Mahon is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Kate Mahon has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 21 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Kate Mahon's work include Prostate Cancer Treatment and Research (28 papers), Cancer, Lipids, and Metabolism (13 papers) and Cancer Genomics and Diagnostics (6 papers). Kate Mahon is often cited by papers focused on Prostate Cancer Treatment and Research (28 papers), Cancer, Lipids, and Metabolism (13 papers) and Cancer Genomics and Diagnostics (6 papers). Kate Mahon collaborates with scholars based in Australia, United States and Canada. Kate Mahon's co-authors include Lisa G. Horvath, Goli Samimi, Kristina Warton, Martin R. Stockler, Gavin Marx, Susan M. Henshall, Hui‐Ming Lin, Howard Gurney, Girish Mallesara and Robert L. Sutherland and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgery.

In The Last Decade

Kate Mahon

51 papers receiving 1.2k citations

Peers

Kate Mahon

PRM

ONCOL

RNMI

Marcin Skrzypski Poland

Giorgia Gurioli Italy

Toshinari Yamasaki Japan

Muhammad Zulfiqar Canada

Martina Kluth Germany

Ronald Tutrone United States

Conrad D. Oja Canada

Corinna Wittmer Germany

Consuelo Buttigliero Italy

Dingwei Ye China

Marcin Skrzypski Poland

Kate Mahon

507 ×0.8

391 ×0.6

PRM

591 ×1.2

333 ×1.0

ONCOL

125 ×0.9

RNMI

Citations per year, relative to Kate Mahon Kate Mahon (= 1×) peers Marcin Skrzypski

Countries citing papers authored by Kate Mahon

Since Specialization

Citations

This map shows the geographic impact of Kate Mahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Mahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Mahon more than expected).

Fields of papers citing papers by Kate Mahon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Mahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Mahon. The network helps show where Kate Mahon may publish in the future.

Co-authorship network of co-authors of Kate Mahon

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Mahon. A scholar is included among the top collaborators of Kate Mahon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Mahon. Kate Mahon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steffens, Daniel, Cherry Koh, Nabila Ansari, et al.. (2025). International Prospective Quality of Life in Patients With Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the United Kingdom and Australia. Diseases of the Colon & Rectum. 68(9). 1074–1084.

Matos, Marco, George Kannourakis, Morteza Aghmesheh, et al.. (2025). Safety, tolerability, and preliminary efficacy of tinodasertib as a monotherapy or in combination with pembrolizumab or irinotecan in metastatic colorectal cancer: Interim results from a phase II open-label, dose-finding, run-in and cohort expansion study.. Journal of Clinical Oncology. 43(4_suppl). 183–183. 1 indexed citations

Li, Tiffany, Hui‐Ming Lin, Hannah C. Timmins, et al.. (2024). Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy. JCO Precision Oncology. 8(8). e2300690–e2300690. 1 indexed citations

Mahon, Kate, Hui‐Ming Lin, Martin R. Stockler, et al.. (2024). Clinical validation of circulating GDF15/MIC‐1 as a marker of response to docetaxel and survival in men with metastatic castration‐resistant prostate cancer. The Prostate. 84(8). 747–755. 5 indexed citations

Fettke, Heidi, Chao Dai, Edmond M. Kwan, et al.. (2023). BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype. EBioMedicine. 95. 104738–104738. 21 indexed citations

Lin, Hui‐Ming, Thy Duong, Kate Mahon, et al.. (2022). Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin. Cancers. 14(19). 4792–4792. 8 indexed citations

Hauser, Christine, Patricia Bukczynska, Nicole Ng, et al.. (2021). Genomic landscape of older versus younger men with metastatic castration-resistant prostate cancer. Asia-Pacific Journal of Clinical Oncology. 17. 1 indexed citations

Lin, Hui‐Ming, Kevin Huynh, Manish Kohli, et al.. (2021). Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 24(3). 860–870. 19 indexed citations

Kohli, Manish, Winston Tan, Tiantian Zheng, et al.. (2020). Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer. EBioMedicine. 54. 102728–102728. 89 indexed citations

10.

Kwan, Edmond M., Heidi Fettke, Maria Docanto, et al.. (2019). Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer. European Urology Focus. 7(1). 63–70. 11 indexed citations

11.

Brown, Kilian G. M., et al.. (2019). Management of colorectal cancer. BMJ. 366. l4561–l4561. 67 indexed citations

12.

Mahon, Kate, Wenjia Qu, Hui‐Ming Lin, et al.. (2018). Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial. European Urology. 76(3). 306–312. 30 indexed citations

13.

Emmett, Louise, Megan Crumbaker, Bao Ho, et al.. (2018). Results of a Prospective Phase 2 Pilot Trial of 177Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression. Clinical Genitourinary Cancer. 17(1). 15–22. 126 indexed citations

14.

Zhang, Alison Y., Kate Mahon, Krishan Rasiah, et al.. (2017). A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer. Annals of Oncology. 28(8). 1903–1909. 10 indexed citations

15.

Lin, Hui‐Ming, Kate Mahon, Jacquelyn M. Weir, et al.. (2017). A distinct plasma lipid signature associated with poor prognosis in castration‐resistant prostate cancer. International Journal of Cancer. 141(10). 2112–2120. 63 indexed citations

16.

Lin, Hui‐Ming, Kate Mahon, Howard Gurney, et al.. (2017). Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer. British Journal of Cancer. 116(8). 1002–1011. 48 indexed citations

17.

Mahon, Kate, Lesley Castillo, Mark D. Chatfield, et al.. (2015). Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer. British Journal of Cancer. 112(8). 1340–1348. 45 indexed citations

18.

Mahon, Kate, Wenjia Qu, James Devaney, et al.. (2014). Methylated glutathione s-transferase 1 (mGSTP1) as a potential plasma epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 32(4_suppl). 11–11. 5 indexed citations

19.

Mahon, Kate, Susan M. Henshall, Robert L. Sutherland, & Lisa G. Horvath. (2011). Pathways of chemotherapy resistance in castration-resistant prostate cancer. Endocrine Related Cancer. 18(4). R103–R123. 76 indexed citations

20.

Kao, Steven, Kate Mahon, Betty Lin, et al.. (2009). Pleural Well-Differentiated Papillary Mesothelioma: A Case Report. Journal of Thoracic Oncology. 4(7). 920–922. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact